OAC
XENT

OMERS Administration Corp’s Intersect ENT, Inc XENT Stock Holding History

OMERS Administration Corp’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-31,900
Closed -$378K – 219
2020
Q1 		$378K Buy
+31,900
New +$707K 0.02% 135

Other funds holding XENT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OMERS Administration Corp's XENT Position: Q2 2020 in Review

OMERS Administration Corp sold out of Intersect ENT, Inc (XENT) in Q2 2020, closing a stake of 31,900 shares — an estimated $378K sold.

OMERS Administration Corp first reported a position in XENT in Q1 2020 and held it in 1 quarter. The position peaked at $378K in Q1 2020. 108 funds tracked by Wall St. Rank hold XENT as of Q2 2020.

  • OMERS Administration Corp reported no remaining Intersect ENT, Inc position as of Q2 2020 after selling out during the quarter.
  • OMERS Administration Corp sold 31,900 Intersect ENT, Inc shares in Q2 2020, an estimated $378K.
  • OMERS Administration Corp first reported a position in Intersect ENT, Inc in Q1 2020 and held it in 1 quarter.
  • OMERS Administration Corp's Intersect ENT, Inc position peaked at $378K in Q1 2020.
  • 108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2020.

Based on OMERS Administration Corp's 13F filing for Q2 2020, filed 14 Aug 2020.